Regulations.gov document
Leveraging Randomized Clinical Trials To Generate Real-World Evidence for Regulatory…
Notice · FDA-2019-N-0001 · posted Jun 10, 2019
Key facts
| Document ID | FDA-2019-N-0001-0004 |
|---|---|
| Title | Leveraging Randomized Clinical Trials To Generate Real-World Evidence for Regulatory Purposes; Public Workshop |
| Document type | Notice |
| Subtype | Public Meetings |
| Agency | FDA |
| Docket | FDA-2019-N-0001 |
| Posted | Jun 10, 2019 |
| Federal Register citation | 84 FR 26882 |
| FR document number | 2019-12113 |
| Comment period opens | Jun 10, 2019 |
| Effective date | Jun 10, 2019 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: